与DNA纳米机器人配备的半机体干细胞作为炎症性肠病组合疗法的一种方式
Hongxiu Yuan1, Gang Wang1, Fangbo Zou1
1Shandong Cancer Hospital and Institute, School of Life Sciences, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, P. R. China.
ACS applied materials & interfaces
|February 28, 2025
概括
一种新型的DNA纳米机器人武装介质干细胞 (MSC) 疗法通过阻断免疫细胞透并促进组织修复以最小的副作用来有效治疗炎症性肠病 (IBD).
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
背景情况:
- 炎症性肠病 (IBD) 需要针对多层次免疫调节通路的先进疗法.
- 目前的治疗方法往往缺乏针对炎症部位的向治疗,这限制了疗效,并导致副作用.
研究的目的:
- 开发一种DNA纳米机器人武装的介质干细胞 (MSC) 疗法,用于增强IBD治疗.
- 研究这种有针对性的方法在减少炎症和促进组织修复方面的有效性.
主要方法:
- 装备有DNA纳米机器人的工程MSC,具有针对Integrin α4和VCAM 1的aptamer.
- 利用四面体DNA (TDN) 作为一个支架,用于阿普坦体固定和MSC附着.
- 在小鼠结肠炎模型中通过尾静脉注射评估治疗疗效.
主要成果:
- 在炎症的结肠组织中针对性地积累工程MSCs.
- 与未经修改的MSCs或单独的阿普坦酶抑制剂相比,结肠炎症的显著减少.
- 证明了增强的免疫调节和组织修复能力.
结论:
- 配备DNA纳米机器人的MSC为IBD提供了一个有前途的向治疗方法.
- 这一策略有效地抑制了淋巴细胞的透,并促进了愈合,减少了全身副作用.
- 对IBD患者没有反应常规抗炎治疗的潜在治疗选择.
相关概念视频
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K


